Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lanreotide versus placebo for tumour reduction in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma (GALANT study): a randomised, multicentre, phase 3 trial with blinded outcome assessment.
Boertien TM, Drent ML, Booij J, Majoie CBLM, Stokkel MPM, Hoogmoed J, Pereira AM, Biermasz NR, Simsek S, Veldman RG, Weterings AJ, Vink JM, Tanck MWT, Fliers E, Bisschop PH. Boertien TM, et al. Among authors: bisschop ph. Lancet Reg Health Eur. 2024 May 13;42:100923. doi: 10.1016/j.lanepe.2024.100923. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 39070749 Free PMC article.
The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga -DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lan reotide on t umour size.
Boertien TM, Drent ML, Booij J, Majoie CBLM, Stokkel MPM, Hoogmoed J, Pereira A, Biermasz NR, Simsek S, Groote Veldman R, Tanck MWT, Fliers E, Bisschop PH. Boertien TM, et al. Among authors: bisschop ph. BMJ Open. 2020 Aug 13;10(8):e038250. doi: 10.1136/bmjopen-2020-038250. BMJ Open. 2020. PMID: 32792446 Free PMC article.
68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas.
Boertien TM, Booij J, Majoie CBLM, Drent ML, Pereira AM, Biermasz NR, Simsek S, Veldman RG, Stokkel MPM, Bisschop PH, Fliers E. Boertien TM, et al. Among authors: bisschop ph. Eur J Hybrid Imaging. 2020 Feb 27;4(1):4. doi: 10.1186/s41824-020-0073-3. Eur J Hybrid Imaging. 2020. PMID: 34191241 Free PMC article.
The PRolaCT studies - a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma.
Zandbergen IM, Zamanipoor Najafabadi AH, Pelsma ICM, van den Akker-van Marle ME, Bisschop PHLT, Boogaarts HDJ, van Bon AC, Burhani B, le Cessie S, Dekkers OM, Drent ML, Feelders RA, de Graaf JP, Hoogmoed J, Kapiteijn KK, van der Klauw MM, Nieuwlaat WCM, Pereira AM, Stades AME, van de Ven AC, Wakelkamp IMMJ, van Furth WR, Biermasz NR; Dutch Prolactinoma Study Group. Zandbergen IM, et al. Trials. 2021 Sep 25;22(1):653. doi: 10.1186/s13063-021-05604-y. Trials. 2021. PMID: 34563236 Free PMC article.
Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging.
van Bunderen CC, van Varsseveld NC, Baayen JC, van Furth WR, Aliaga ES, Hazewinkel MJ, Majoie CB, Freling NJ, Lips P, Fliers E, Bisschop PH, Drent ML. van Bunderen CC, et al. Among authors: bisschop ph. Pituitary. 2013 Jun;16(2):158-67. doi: 10.1007/s11102-012-0395-7. Pituitary. 2013. PMID: 22535510 Free PMC article.
Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG).
de Laat JM, Dekkers OM, Pieterman CR, Kluijfhout WP, Hermus AR, Pereira AM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, de Herder WW, Valk GD. de Laat JM, et al. Among authors: bisschop ph. J Clin Endocrinol Metab. 2015 Sep;100(9):3288-96. doi: 10.1210/JC.2015-2015. Epub 2015 Jun 30. J Clin Endocrinol Metab. 2015. PMID: 26126205
165 results